tiprankstipranks
Trending News
More News >

My Real Invests - New Portfolio

Jerome Houboi

My Real Invests
Individual Investor
Ranked #452,082 out of 833,195 TipRanks' Investors
Success Rate
51%
56 out of 110
profitable transactions
Average Return
4.68%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 7.89%
6-Month Return-
12-Month Return-
YTD Return▲ 10.01%
Total Return▲ 10.01%

Best Trade

Opened at
Closed at
Gain▲ 137.10%

Bio

Performance

13.36%0-13.36%
▲ 11.63%
▲ 6.28%
May 2025
▲ 9.25%
▲ 5.14%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 1.88%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 3.12%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 13.36%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 5.15%
Oct 2025
▼ 3.57%
▲ 0.19%
▼ 10.05%
Nov 2025
▼ 1.96%
▼ 0.12%
▼ 2.34%
Dec 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 11.63%▲ 6.28%
▲ 9.25%▲ 5.14%
▲ 7.60%▲ 2.30%▲ 1.88%
▲ 2.76%▲ 2.05%▲ 3.12%
▲ 12.88%▲ 3.56%▲ 13.36%
▲ 10.96%▲ 2.38%▲ 5.15%
▼ 3.57%▲ 0.19%▼ 10.05%
▼ 1.96%▼ 0.12%▼ 2.34%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
IonQ
3.37%
▼ 3.37%
3
Buy
Nov 25, 2025
BioAtla
2.25%
▼ 13.06%
3
Buy
Nov 19, 2025
PDD Holdings
▼ 12.49%
2
Close
Nov 19, 2025
Alphabet Class A
▲ 25.61%
5
Close
Nov 13, 2025
BICO Group AB Class B
0.58%
▼ 34.94%
2
Buy
Nov 04, 2025
Tiziana Life Sciences
▲ 5.15%
5
Close
Nov 03, 2025
ProMIS Neurosciences
▼ 6.59%
2
Close
Nov 03, 2025
OnKure Therapeutics
▲ 22.47%
2
Close
Nov 03, 2025
Moleculin Biotech
▼ 1.94%
2
Close
Nov 03, 2025
Regeneron
2.2%
▲ 19.72%
1
Open
Nov 03, 2025
Axsome Therapeutics
1.75%
▲ 12.45%
1
Open
Nov 03, 2025
BioMarin Pharmaceutical
1.75%
▲ 15.70%
1
Open
Nov 03, 2025
JD.com, Inc. Class A
1.23%
▼ 12.50%
1
Open
Nov 01, 2025
NRX Pharmaceuticals
0.7%
▼ 24.30%
2
Buy
Oct 30, 2025
Intellia Therapeutics
2.31%
▼ 42.07%
2
Buy
Oct 27, 2025
Iridium Communications
▼ 34.77%
3
Close
Oct 23, 2025
ATAI Life Sciences
0.76%
▼ 28.65%
1
Open
Oct 23, 2025
Sana Biotechnology
3.09%
▼ 7.25%
2
Buy
Oct 16, 2025
Rocket Lab USA
▲ 42.46%
3
Close
Oct 10, 2025
Planet Labs PBC
▲ 87.82%
4
Close
Oct 10, 2025